BrainCool AB (publ) (STO:BRAIN)
0.5280
-0.0120 (-2.22%)
Jan 21, 2026, 5:29 PM CET
BrainCool AB Revenue
BrainCool AB had revenue of 14.89M SEK in the quarter ending September 30, 2025, with 59.90% growth. This brings the company's revenue in the last twelve months to 46.13M, up 13.41% year-over-year. In the year 2024, BrainCool AB had annual revenue of 42.69M with 55.79% growth.
Revenue (ttm)
46.13M
Revenue Growth
+13.41%
P/S Ratio
4.62
Revenue / Employee
2.31M
Employees
21
Market Cap
213.23M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 42.69M | 15.29M | 55.79% |
| Dec 31, 2023 | 27.40M | -2.65M | -8.81% |
| Dec 31, 2022 | 30.05M | 6.58M | 28.01% |
| Dec 31, 2021 | 23.48M | 7.52M | 47.14% |
| Dec 31, 2020 | 15.96M | 4.15M | 35.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 35.85B |
| Swedish Orphan Biovitrum AB | 27.85B |
| Medicover AB | 25.67B |
| Elekta AB | 17.57B |
| Asker Healthcare Group AB | 16.41B |
| AddLife AB | 10.53B |
| Nolato AB | 9.57B |
| Vitrolife AB | 3.51B |